Subject(s)

Autoantibodies/adverse effects , Autoantibodies/immunology , Autoimmune Diseases/etiology , Autoimmune Diseases/immunology , COVID-19/complications , COVID-19/physiopathology , Models, Immunological , SARS-CoV-2/pathogenicity , Aging/immunology , Annexin A2/immunology , Autoantibodies/isolation & purification , Autoimmune Diseases/microbiology , Autoimmune Diseases/virology , B-Lymphocytes/immunology , B-Lymphocytes/pathology , Blood Coagulation/immunology , Blood Vessels/immunology , Blood Vessels/pathology , Brain/immunology , Brain/pathology , COVID-19/etiology , COVID-19/immunology , COVID-19/pathology , COVID-19/virology , Critical Illness , Cytokine Release Syndrome/complications , Cytokine Release Syndrome/immunology , Cytokine Release Syndrome/pathology , Cytokine Release Syndrome/physiopathology , Female , HLA-DRB1 Chains/immunology , Helicobacter pylori/immunology , Helicobacter pylori/pathogenicity , Herpesvirus 4, Human/immunology , Herpesvirus 4, Human/pathogenicity , Humans , Interferon Type I/antagonists & inhibitors , Interferon Type I/immunology , Male , Myocardium/immunology , Myocardium/pathology , Phospholipids/immunology , Racial Groups , SARS-CoV-2/immunology , SARS-CoV-2/isolation & purification , Sex Characteristics , Streptococcus pyogenes/immunology , Streptococcus pyogenes/pathogenicity , Time Factors , Post-Acute COVID-19 Syndrome